FDA Finalizes Guidance on Presenting Quantitative Efficacy and Risk Information in DTC Promotion | King & Spalding
On June 28, 2023, the U.S. Food and Drug Administration (“FDA”) issued final guidance on Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer (DTC) Promotional...
Source: jdsupra.com